National
Clinton: LGBT-inclusion ‘the smart thing’ for U.S. foreign policy
Secretary speaks before LGBT Foreign Service officers
Secretary of State Hillary Clinton (Washington Blade photo by Michael Key)
Secretary of State Hillary Clinton delivered on Wednesday what might be her last public address before an LGBT audience as chief diplomat for the United States when she told group of LGBT Foreign Service officers their service is integral to the country.
“Creating an LGBT-welcoming workplace is not just the right thing to do, it’s also the smart thing,” Clinton said. “And part of that is because the nature of diplomacy has changed and we should and need to keep up. Today, we expect our diplomats to build relationships not just with their counterparts in foreign governments, but from people from every continent and every walk of life, and, in order to do that, we need a diplomatic core that is as diverse as the world we work in.”
Additionally, Clinton said having an LGBT-inclusive State Department makes the Foreign Service corps “better advocates” for American values.
“When anyone is persecuted anywhere and that includes when LGBT people are persecuted, we’re kept from fully participating in their societies,” Clinton said. “They suffer, but so do we. We are diminished because our commitment to the human rights of all people has to be a continuing obligation and mission of everyone who serves in the government of the United States.”
Clinton delivered the remarks in Benjamin Franklin room at the State Department to observe the 20th anniversary of the department’s LGBT affinity group, Gays & Lesbians in Foreign Affairs Agencies, or GLIFAA.
She reminded the estimated 200 people in attendance that world in which GLIFAA was created was much different than today and the organization has worked over the course of 20 years to create a fairer workplace for LGBT Foreign Service officers.
“As we heard, in 1992, you could be fired for being gay,” Clinton said. “Just think about all of the exceptional public servant — the brilliant strategists, the linguists, the experts — fired for no reason other than their sexual orientation. Think of what we lost because we were unable of their hard work, expertise and experience.”
Clinton also gave recognition to Tom Gallagher, whom she said joined the State Department in 1965 and in the early 1970’s became the first openly gay Foreign Service officer. He was in the audience during Clinton’s speech and rose when the secretary mentioned him.
“He served in the face of criticism and threats, but that did not stop him from serving,” Clinton said. “I want to take this moment just to recognize him, but also to put into context what this journey has meant for people for people of Tom and my generation because I don’t want any of you who are younger ever to take for granted what it took for people like Tom Gallagher to pave the way for all of you. It is not a moment for us to be nostaglic; it is a way for us to remember.”
The speech occurs almost one year after Clinton gave a high-profile speech in Geneva in favor of LGBT human rights, telling LGBT people that face human rights abuses overseas they “have an ally in the United States of America.” Clinton noted her speech from the previous year during her remarks at the State Department.
“When I gave that speech in Geneva and said we were going to make this a priority for American foreign policy, I didn’t see it as something special, something that was added on to everything else we do, but something that was integral to who we are and what we stand for,” Clinton said.
Toby Quaranta, who’s gay and president of the D.C Young Democrats, was among those in attendance and said the speech was “an example of why she is such a popular secretary of state.”
“She wants to make advances for LGBT people not just as a way to advance the cause of human rights, but also as a way to advance American interests abroad,” Quaranta said. “It’s a moral issue with a pragmatic end. That’s her way of doing business, and that is why she has been so successful as secretary of state.”
No new announcements were made during the State Department address, but the event was geared toward thanking those present as opposed to addressing policy issues.
Clinton gave no update during the speech on where she stands on marriage equality. She remains one of the few high-profile Democrats who’s yet to publicly endorse same-sex marriage and has remained silent in the issue even after her employer President Obama came out for marriage equality in May.
Also absent from Clinton’s speech was any mention of anti-gay legislation in Uganda that’s received considerable international attention out of fears the bill may soon be headed toward passage. It would institute a sentence of life in prison for homosexuality acts and possibly the death penalty.
But Clinton did tout the LGBT achievements the State Department has made under her watch. Among them are extending benefits to the same-sex partners of Foreign Service officers. On transgender issues, the department instituted policy against workplace discrimination for transgender employees and eased the process to allow transgender Americans to change the gender marker on their passports.
“Together we have worked to make something very simple and right come true: Our people should not have to choose between serving the country they love and sharing a life with the people with they love,” Clinton said.
Cheryl Mills, Clinton’s chief of staff and a long-time adviser who worked on her 2008 presidential campaign, also commended those present as she said her boss seeks to ensure each person across the globe can “live up to his or her God-given potential.”
“That principle is a very simple one, but its implementation too often requires courage and persistence, relentlessness and willingness to actual do something when doing nothing is absolutely the easiest course of action,” Mills said. “Those who have been part of and stayed with GLIFAA, they have always managed to do something, and the work that you all have done together has brought the change that we have seen in the department.”
Clinton has indicated that she intends to step down as secretary of state after the conclusion of Obama’s first term. Speculation persists that she may pursue that Democratic nomination for the presidency when Obama completes his second and final term in 2016, although she hasn’t stated she’d run.
Lane Hudson, a gay Democratic activist and outspoken Clinton supporter, said he expects her to maintain a strong relationship with the LGBT community whatever her course of action she pursues after she leaves the State Department.
“Given her long history with the LGBT community and her exemplary record on issues of equality at the State Department, I fully expect there to be a meaningful ongoing relationship between her and the community, whether she pursues the presidency or continues to advocate for equality for all as a private citizen,” Hudson said.
Others who spoke before the audience were GLIFAA President Ken Kero-Mentz, USAID Deputy Administrator Donald Steinberg, and Daniel Baer, who’s gay and deputy assistant secretary of state for the Bureau of Democracy, Human Rights & Labor.
Notable members of the LGBT community who were in the audience included U.S. ambassador to New Zealand David Huebner, former U.S. ambassador to Romania Michael Guest, Human Rights Campaign President Chad Griffin, White House LGBT liaison Gautam Raghavan and Amanda Simpson, who was first openly transgender woman political appointee in any U.S. administration.
NOTE: This article has been updated to include a statement from Toby Quaranta.
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
